• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
NTI 3.23% 6.0¢

NEUROTECH INTERNATIONAL LIMITED

Neurotech International Limited is an Australia-based clinical-stage biopharmaceutical... Neurotech International Limited is an Australia-based clinical-stage biopharmaceutical development company. The Company is focused predominately on pediatric neurological disorders with a broad-spectrum oral cannabinoid drug therapy called NTI164. It has completed a Phase II/III randomized, double-blind, placebo-controlled clinical trial in autism spectrum disorder (ASD) with clinically significant benefits reported across a number of clinically validated measures and safety. In addition, it has completed and reported significant and clinically meaningful Phase I/II trials in ASD and pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS) and pediatric acute-onset neuropsychiatric syndrome (PANS), collectively PANDAS/PANS along with Rett Syndrome. NTI164 is being developed as a therapeutic drug product for a range of neurological disorders in children where neuroinflammation is involved.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
NTI
NTI - Media & News
06/06/24 0 160
06/06/24 Last post  ma420 Comments Created with Sketch.  0  Views Created with Sketch.  160 
NTI 06/06/24 15 3.3K
06/06/24 Last post  PL24682468z Comments Created with Sketch.  15  Views Created with Sketch.  3.3K 
NTI 06/06/24 3 827
06/06/24 Last post  Kookaburra777 Comments Created with Sketch.  3  Views Created with Sketch.  827 
NTI
News: NTI Neurotech International Formalises Strategic Partnership With Fenix Innovation
03/06/24 0 148
03/06/24 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  148 
NTI
US to reschedule weed
21/05/24 4 2.1K
21/05/24 Last post  $$$$$$$$ Comments Created with Sketch.  4  Views Created with Sketch.  2.1K 
NTI
International Recognition
17/05/24 2 1.0K
17/05/24 Last post  levendful Comments Created with Sketch.  2  Views Created with Sketch.  1.0K 
NTI 14/05/24 38 10K
14/05/24 Last post  Bluebush Comments Created with Sketch.  38  Views Created with Sketch.  10K 
NTI
Chart - NTI
2 3
11/05/24 139 54K
11/05/24 Last post  Ozibobby Comments Created with Sketch.  139  Views Created with Sketch.  54K 

See All Discussions arrow Created with Sketch.

Timeline

Further clinical benefit at 52 weeks in PANDAS/PANS patients
06 Jun 08:43
 
NTI Formalises Strategic Partnership with Fenix Innovation
03 Jun 10:58
 
Notice of Change of Auditor
08 May 18:28
 
Change of Director's Interest Notice
08 May 13:58
 
Investor Webinar on Rett Syndrome Clinical Trial Results
06 May 09:35
 
Investor Presentation
06 May 09:34
 
View More arrow Created with Sketch.
(20min delay)
Last
6.0¢
Change
-0.002(3.23%)
Mkt cap ! $61.04M
Open High Low Value Volume
6.4¢ 6.4¢ 6.0¢ $46.18K 745.1K

Buyers (Bids)

No. Vol. Price($)
4 241999 6.0¢
 

Sellers (Offers)

Price($) Vol. No.
6.4¢ 178732 1
View Market Depth
Last trade - 16.10pm 07/06/2024 (20 minute delay) ?
Last
6.3¢
  Change
-0.002 ( 1.61 %)
Open High Low Volume
6.3¢ 6.3¢ 6.3¢ 116286
Last updated 15.23pm 07/06/2024 ?
NTI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.